← Back to all signals
RESEARCH PAPER ANALYSIS

Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients.

AI interpretation is pending for this paper.

Open original publication →
PMID40961165
JournalPloS one
Publication Date2025-09-17
Ingested2026-08-02 12:03 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: It is well-known that lymphoma patients undergoing treatment are at risk of hepatitis B virus (HBV) reactivation. This study aims to explore the risk factors for HBV reactivation in lymphoma patients who tested negative for both hepatitis B surface antigen (HBsAg) and HBV DNA before treatment, during their course of therapy. It provides clinical evidence for early intervention in HBV reactivation and rational preventive antiviral treatment. METHODS: From January 2019 to December 2021, a total of 1,229 patients were diagnosed with lymphoma at Guangdong Provincial People's Hospital. Among them, 616 patients who tested negative for both HBsAg and HBV DNA and underwent therapy were recruited for the study. The recruited patients had a median age of 53.9 years (range: 14-88 years), with 358 males (58.12%) and 258 females (41.88%). The risk factors associated with HBV reactivation in these patients were then analyzed. RESULTS: Among the 616 lymphoma patients enrolled in this study, 44 patients (7.14%, 44/616) exhibited HBV reactivation. Notably, the rate of HBV reactivation was significantly higher in patients with hepatitis B core antibody (HBcAb) (+) (10.00%) compared to those with HBcAb (-) (1.46%) (P < 0.001, OR = 7.52). An analysis of HBV reactivation rates across different age groups demonstrated a statistically significant difference (P = 0.002). In particular, patients aged over 60 years showed a markedly elevated rate of HBV reactivation compared to those in other age brackets (P < 0.001). Conversely, no statistically significant differences in HBV reactivation rates were observed between patients of different genders (P = 0.637, OR = 0.855) or across varying treatment durations (P = 0.851). CONCLUSION: For lymphoma patients undergoing treatment, HBV reactivation may occur even if both HBsAg and HBV DNA are negative at the initiation of treatment. It is noteworthy that this study found that patients with HBcAb (-) also experienced HBV reactivation. Therefore, patients who are negative for HBsAg, HBcAb, and HBV DNA should also be closely monitored to mitigate the risk of HBV reactivation.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 From Childhood Ingestion to Adult Obstruction: A Long-Retained Synthetic Gastric Foreign Body. Cureus 59.5 2 Deep learning-based detection of pediatric brain tumor presence on MRI. Neuro-oncology advances 58.4 3 Efficacy and safety of Heshu Xiaoji pills combined with standard treatment strategy in hepatitis B virus-related hepatocellular carcinoma: a single-center, open-label, prospective controlled, real-world cohort study. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 69.04 4 Bioelectrical impedance parameters and nutritional status of pediatric patients with hematological malignancies: a cross-sectional study. Nutricion hospitalaria 65.8 5 Single-cell analysis and EpCAM-based microfluidic chip detection of PD-L1 on circulating tumor cells for prognostic prediction in epithelial ovarian cancer. Frontiers in oncology 55.2 6 Navigating CAR-T translation in Australia: lessons from an academic program. Frontiers in medicine 71.9 7 Pediatric hyperuricemia: genetic basis, metabolic mechanisms, and clinical implications. Frontiers in endocrinology 63.25 8 Weighted epigenetic site correlation network analysis of chemotherapy impacts on osteosarcoma cancer survivors' male fertility, sperm, and endocrine parameters. Environmental epigenetics 62.94 9 Acute Sector Cancer Physiotherapy Service Provision and Workforce. Irish medical journal 63.14 10 Influencing Factors Associated With Infantile Hemangioma: A Case-Control Study Among Chinese Pediatric Populations. The Journal of dermatology 71.4 11 ODC1 inhibition and neuroblastoma: A drug-target Mendelian randomization, eQTL colocalization and drug sensitivity study. British journal of clinical pharmacology 66.76 12 Intraosseous calvarial haematoma mimicking a skull tumour in a child with Noonan syndrome: a case report. Journal of surgical case reports 45.5 13 Head and Neck Rhabdomyosarcoma in Children: An Otolaryngological Perspective on Diagnostic and Therapeutic Approaches. Current oncology reports 73.54 14 Pilomatricoma in an Octogenarian: A Case Report of an Exceptional Late-Life Presentation. The American journal of case reports 47.5 15 Blinatumomab-induced catastrophic immune effector cell-associated neurotoxicity with diffuse cerebral edema in a patient with ALL: Case report. International journal of clinical pharmacology and therapeutics 67.0 16 Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns. European journal of haematology 66.92 17 Demographics, risk factor profiles and etiologies in young ischemic and hemorrhagic stroke - the United Kingdom Young Stroke Study (UKYSS). Journal of neurology 59.1 18 Surgical management of quadrigeminal arachnoid cysts in children: A single-center study of 15 cases according to the Cinalli classification. Neurosurgical review 61.8 19 Recurrent Cardiac Arrest in a Pediatric Patient with Hypertrophic Cardiomyopathy and a Myocardial Bridge: Player or Spectator? Pediatric cardiology 49.9 20 Subperineural 'onion-peeling' dissection for maximizing extent of resection and facial nerve preservation for onco-functional balance in vestibular schwannoma surgery. Journal of neuro-oncology 67.0 21 Is vitreoretinal traction the cause of 'Combined Hamartoma of the Retina and Retinal Pigment Epithelium' (CHRRPE)? A case series and proposal for 'Traction-Induced Retinal and Retinal Pigment Epithelium Lesion' (TRIPEL). Retina (Philadelphia, Pa.) 54.0 22 1Unilateral Le Fort I Advancement Versus Dentoalveolar Transport Distraction in Patients With Large Alveolar Clefts: Protocol for a Prospective Observational Study. JMIR research protocols 60.9 23 Epidemiology and long-term survival of primary central nervous system germ cell tumors in Korea: a nationwide population-based study, 2005-2022. Neuroepidemiology 59.12 24 Frequency and prognostic outcomes of emergency diagnosis in 13 non-neoplastic conditions in England: A population-based cohort study using linked electronic health records of 1.7 million patients. PLoS medicine 65.5 25 Burden of early-onset pancreatic cancer and its association with risk factors in women of childbearing age. PloS one 65.0 26 Circulating CTRP-1 levels are elevated in women with polycystic ovary syndrome: A case-control study. PloS one 64.0 27 Predictive Risk Model for Early Post-Treatment Acute Care Use in Adolescent and Young Adult Patients With Cancer. JCO oncology practice 69.74 28 Cryoablation of Malignancies and Aggressive Benign Diseases in Children: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. Journal of vascular and interventional radiology : JVIR 64.7 29 On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial. The lancet. Gastroenterology & hepatology 84.4 30 Methylation profile scores in child and adolescent health: a practical guide. The Lancet. Child & adolescent health 61.1 31 Somatic mutations in human ontogenesis and their impact on health. Ageing research reviews 40.0 32 MicroRNA profiles as diagnostic tools in pediatric acute lymphoblastic leukemia. Clinica chimica acta; international journal of clinical chemistry 63.0
PATIENT-FRIENDLY SUMMARY

Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic